J. Navarro

DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents

Miguel Relloso, Amaya Puig‐Kröger, Óscar M. Pello et al. · The Journal of Immunology · 2002 · 295 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis

Clara de Andrés, Carol Aristimuño, Virginia de las Heras et al. · Journal of Neuroimmunology · 2006 · 132 citations

Life Sciences, Immunology, Neurology +15

In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

Roberto Lorusso, Maria Elena De Piero, Silvia Mariani et al. · The Lancet Respiratory Medicine · 2022 · 79 citations · Full text

Medicine, Surgery, Cardiothoracic Surgery +12

Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users

Javier Carbone, Juana Gil, José M. Benito et al. · AIDS · 2000 · 75 citations

Life Sciences, Immunology, Infectious Diseases +17

Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome

Diana Alecsandru, L. Valor, Silvia Sánchez‐Ramón et al. · Clinical & Experimental Immunology · 2011 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17